Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Jury Deliberates Murder Charges in Meningitis Case

By MaryBeth DiDonna | March 21, 2017

Closing arguments have been made, and now it’s up to a federal jury whether to convict the former president of the New England Compounding Center of murder.

Barry Cadden is facing 25 counts of murder for a 2012 fungal meningitis outbreak, which is said to have resulted from steroids compounded by NECC. His other counts include fraud, conspiracy, and racketeering.

The meningitis outbreak killed 64 people and sickened over 700 others. Federal investigators have blamed contaminated drugs, made at the NECC facility, for causing the outbreak.

Read more: Pharmacists from Fatal Meningitis Outbreak Facing Trial

A federal prosecutor has asked the jury to convict Cadden on second-degree murder and other charges, arguing that he knowingly broke rules, ignored a contaminated cleanroom, and prioritized profit over safety. Assistant U.S. Attorney George Varghese compared Cadden’s actions to “playing a game of Russian Roulette” by shipping out vials of drugs that had not been tested as promised.

Read more: Meningitis Trial Testimony Describes Cleanroom’s “Locker Room” Atmosphere

However, Cadden’s attorney, Bruce Singal, has argued that this is a public tragedy, not murder. Singal said that federal investigators did not succeed in identifying a single act of Cadden’s that would have caused the outbreak, and said that prosecutors introduced extraneous evidence and presented testimony about victims’ deaths to play on the jurors’ emotions. Singal, furthermore, pinned the blame for the contamination on Glenn Chin, a supervisory pharmacist at NECC, and said that Chin was the one in charge of the cleanroom and therefore Chin should shoulder responsibility. Chin has been charged identically to Cadden and should be going on trial once Cadden’s case is concluded.

The NECC filed for bankruptcy in 2014, and the following year it agreed to pay $200 million to victims and creditors — this money included funds that had been seized from Cadden.

Cadden could be dealt a life sentence, depending on the jury’s verdict on the counts related to the deaths. The case was given to the jury on March 16, and deliberations began the morning of March 17. The jurors must determine if second-degree murder took place under the standards of a state where a death took place … Cadden is charged with 25 deaths across seven states.

Read more: Old Mattresses, Mold, and Mickey Mouse: Meningitis Trial Continues
 

The jurors asked U.S. District Judge Richard G. Stearns for clarification on the charges during their first day of deliberations, questioning whether Cadden’s actions constituted second-degree murder or negligence. Stearns replied that negligent conduct means that the individual has failed to act as a prudent person would under the circumstances; and that second-degree murder holds a higher threshold, as it means that an individual acts in a way that that he or she knows would likely cause death or serious injury. Should the jury determine that Cadden was “negligent,” it means he would not meet the requirements for one of the racketeering charges; however, additional racketeering charges would remain.

Deliberations continued on March 20.

Related Articles Read More >

6 essentials for seismic rated cleanrooms
Critical Spaces Control Platform
Phoenix Critical Spaces Control Platform uses automation to direct airflow
Endiatx
Endiatx aims to boldly go beyond traditional endoscopy and, eventually, redefine surgical scale
FMN Laboratory researcher in a cleanroom
Take our quiz to test your cleanroom IQ, covering everything from ISO Classes to ULPA filtration
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE